Improving Treatment For Parasitic Worms

As part of the Tribendimidine (TrBD) Consortium, PATH and partners are advancing TrBD—an anthelmintic drug with demonstrated excellent efficacy against soil-transmitted helminth (STH) infections—as an additional drug option for control and treatment of STH. Integration of TrBD into global mass drug administration campaigns could accelerate progress to eliminate STH in endemic regions.

Publication date: August 2017

Improving Treatment For Parasitic Worms

635.2 KB PDF

Hard copies are not available.

View Resource